Ganglio centinela positivo en estadios iniciales de cáncer de mama. 2018. Resumen de recomendaciones

Uriburu, Juan Luis; Rostagno, Román; Maciel, Alejandra; Nobalía, Cristina; Rafailovici, Luisa; Coló, Federico; Hauszpigiel, Gustavo; Vico, Clelia; Frahm, Isabel.
Rev. argent. mastología ; 37(136): 12-56, oct. 2018. ilus
Artículo en Español | LILACS, BINACIS | ID: biblio-1117922

Documentos relacionados

  1. SENTINEL LYMPH NODES DETECTION METHOD IN BREAST CANCER.
  2. Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes.
  3. How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR<sup>+</sup>/HER2<sup>-</sup> Breast Cancer in the Post-RxPONDER Era?
  4. Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
  5. Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
  6. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
  7. Failure of sentinel lymph node mapping in breast cancer patients qualified for treatment sparing axillary lymph nodes-Clinical importance and management strategy-One-center analysis.
  8. Repeat sentinel lymph node surgery for locally recurrent breast cancer after prior mastectomy.
  9. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
  10. Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.